MT-RNR1 930G>A is assigned an uncertain risk of aminoglycoside-induced hearing loss based on inadequate evidence. Screening of individuals with aminoglycoside-hearing loss identified this variant in one study (18830133). Therefore, consensus among experts was uncertain risk of aminoglycoside-induced hearing loss due to insufficient evidence. While PMID 18830133 states that "..., 11 of the 151 sequences demonstrated an A > G transition at base position 930. Two of these patients had moderate-to-severe hearing loss." Table 3 of the article shows the G allele as the Human consensus and the 11 subjects as having the A allele. Furthermore, the guideline authors have reviewed institutional sample data and confirmed that the G allele is the reference allele. Therefore the variant is referenced as m.930G>A as of October 2025.